Why Novavax Could Become a Latecomer Leader in the COVID Vaccine Race

Keith Speights, The Motley Fool
·7 min read

In this Motley Fool Live video recorded on Jan. 6, 2021, Healthcare and Cannabis Bureau Chief Corinne Cardina and Fool.com writer Keith Speights discuss why Novavax could become a latecomer leader in the COVID vaccine market. Corinne Cardina: Let's talk about a couple of the other vaccine companies that are not yet authorized and being administered.

Continue reading